Found: 46
Select item for more details and to access through your institution.
Thyroid Diseases and Breast Cancer.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020156
- By:
- Publication type:
- Article
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2398, doi. 10.3390/ijms24032398
- By:
- Publication type:
- Article
Ketogenic Diet Increases Serum and White Adipose Tissue SIRT1 Expression in Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15860, doi. 10.3390/ijms232415860
- By:
- Publication type:
- Article
Is Melanoma Progression Affected by Thyroid Diseases?
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 10036, doi. 10.3390/ijms231710036
- By:
- Publication type:
- Article
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3724, doi. 10.3390/ijms23073724
- By:
- Publication type:
- Article
Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2560, doi. 10.3390/ijms20102560
- By:
- Publication type:
- Article
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1405, doi. 10.3390/ijms20061405
- By:
- Publication type:
- Article
High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 2, p. 504, doi. 10.1210/jc.2010-1688
- By:
- Publication type:
- Article
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 531, doi. 10.1007/s10637-016-0358-3
- By:
- Publication type:
- Article
Thyroid diseases and skin autoimmunity.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2018, v. 19, n. 4, p. 311, doi. 10.1007/s11154-018-9450-7
- By:
- Publication type:
- Article
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.750380
- By:
- Publication type:
- Article
Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121514
- By:
- Publication type:
- Article
Association of Thyroid Diseases with Primary Extra-Thyroidal Malignancies in Women: Results of a Cross-Sectional Study of 6,386 Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0122958
- By:
- Publication type:
- Article
Sutureless Repair for Open Treatment of Inguinal Hernia: Three Techniques in Comparison.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 589, doi. 10.3390/jcm13020589
- By:
- Publication type:
- Article
Thyroid Autoimmunity and SARS-CoV-2 Infection.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6365, doi. 10.3390/jcm12196365
- By:
- Publication type:
- Article
Insights on the Association between Thyroid Diseases and Colorectal Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2234, doi. 10.3390/jcm12062234
- By:
- Publication type:
- Article
Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same Coin.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5096, doi. 10.3390/jcm11175096
- By:
- Publication type:
- Article
Expression and Clinical Utility of Transcription Factors Involved in Epithelial–Mesenchymal Transition during Thyroid Cancer Progression.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4076, doi. 10.3390/jcm10184076
- By:
- Publication type:
- Article
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
- Published in:
- British Journal of Dermatology, 2024, v. 191, n. 4, p. 568, doi. 10.1093/bjd/ljae225
- By:
- Publication type:
- Article
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1386510
- By:
- Publication type:
- Article
Papillary Thyroid Cancer Prognosis: An Evolving Field.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5567, doi. 10.3390/cancers13215567
- By:
- Publication type:
- Article
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3637, doi. 10.3390/cancers12123637
- By:
- Publication type:
- Article
Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology?
- Published in:
- BMC Clinical Pathology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6890-13-7
- By:
- Publication type:
- Article
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 626, doi. 10.1007/s10637-014-0108-3
- By:
- Publication type:
- Article
Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 144, n. 3, p. 683, doi. 10.1007/s10549-014-2893-y
- By:
- Publication type:
- Article
Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 2, p. 275, doi. 10.1002/ijc.21842
- By:
- Publication type:
- Article
CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers.
- Published in:
- International Journal of Endocrinology, 2018, p. 1, doi. 10.1155/2018/1742951
- By:
- Publication type:
- Article
TSH Receptor and Thyroid-Specific Gene Expression in Human Skin.
- Published in:
- Journal of Investigative Dermatology, 2010, v. 130, n. 1, p. 93, doi. 10.1038/jid.2009.180
- By:
- Publication type:
- Article
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer.
- Published in:
- International Journal of Oncology, 2017, v. 50, n. 4, p. 1413, doi. 10.3892/ijo.2017.3907
- By:
- Publication type:
- Article
Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.
- Published in:
- Endocrine (1355008X), 2016, v. 52, n. 2, p. 287, doi. 10.1007/s12020-015-0700-0
- By:
- Publication type:
- Article
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development.
- Published in:
- Human Reproduction Update, 2014, v. 20, n. 6, p. 884, doi. 10.1093/humupd/dmu028
- By:
- Publication type:
- Article
Thyroid and renal cancers: A bidirectional association.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951976
- By:
- Publication type:
- Article
Vitiligo and Autoimmune Thyroid Disorders.
- Published in:
- Frontiers in Endocrinology, 2017, p. 1, doi. 10.3389/fendo.2017.00290
- By:
- Publication type:
- Article
Molecular Targeted Therapies of Aggressive Thyroid Cancer.
- Published in:
- Frontiers in Endocrinology, 2015, v. 6, p. 1, doi. 10.3389/fendo.2015.00176
- By:
- Publication type:
- Article
A New Aurora in Anaplastic Thyroid Cancer Therapy.
- Published in:
- International Journal of Endocrinology, 2014, p. 1, doi. 10.1155/2014/816430
- By:
- Publication type:
- Article
Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 1121, doi. 10.3390/ijms25021121
- By:
- Publication type:
- Article
In papillary thyroid carcinoma BRAF<sup>V600E</sup> is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
- Published in:
- Clinical Endocrinology, 2012, v. 77, n. 5, p. 780, doi. 10.1111/j.1365-2265.2012.04465.x
- By:
- Publication type:
- Article
Iodized Salt May Not Be Sufficient to Guarantee an Adequate Iodine Intake in Pregnant Women.
- Published in:
- Nutrients, 2023, v. 15, n. 19, p. 4182, doi. 10.3390/nu15194182
- By:
- Publication type:
- Article
Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity.
- Published in:
- Nutrients, 2022, v. 14, n. 5, p. N.PAG, doi. 10.3390/nu14050983
- By:
- Publication type:
- Article
Iodine: Its Role in Thyroid Hormone Biosynthesis and Beyond.
- Published in:
- Nutrients, 2021, v. 13, n. 12, p. 4469, doi. 10.3390/nu13124469
- By:
- Publication type:
- Article
Iodine Status in Schoolchildren and Pregnant Women of Lazio, a Central Region of Italy.
- Published in:
- Nutrients, 2019, v. 11, n. 7, p. 1647, doi. 10.3390/nu11071647
- By:
- Publication type:
- Article
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.
- Published in:
- Oncology Reports, 2018, v. 39, n. 5, p. 2306, doi. 10.3892/or.2018.6305
- By:
- Publication type:
- Article
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
- Published in:
- Oncology Reports, 2018, v. 39, n. 5, p. 2225, doi. 10.3892/or.2018.6306
- By:
- Publication type:
- Article
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Increased expression of urokinase plasminogenactivator and its cognate receptor in humanseminomas.
- Published in:
- BMC Cancer, 2010, v. 10, p. 151, doi. 10.1186/1471-2407-10-151
- By:
- Publication type:
- Article